A Phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease.

Source:http://linkedlifedata.com/resource/pubmed/id/11148571

Cancer 2001 Jan 1 91 1 144-54

Download in:

View as

Triples

General Info

PMID
11148571